We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-10.1%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.98B
AUM Growth
+$65.7M
Cap. Flow
+$343M
Cap. Flow %
17.32%
Top 10 Hldgs %
50.43%
Holding
310
New
10
Increased
122
Reduced
100
Closed
37
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ES icon
151
Eversource Energy
ES
$27.8B
$913K 0.05%
10,810
-1,597
-13% -$142K
GE icon
152
GE Aerospace
GE
$368B
$911K 0.05%
22,967
+54
+0.2% +$2.62K
DUK icon
153
Duke Energy
DUK
$98.4B
$907K 0.05%
8,465
+368
+5% +$40.5K
TMO icon
154
Thermo Fisher Scientific
TMO
$214B
$907K 0.05%
1,670
+250
+18% +$138K
VOT icon
155
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$890K 0.04%
5,073
-26
-0.5% -$5.03K
IEZ icon
156
iShares US Oil Equipment & Services ETF
IEZ
$353M
$879K 0.04%
55,040
-3,836
-7% -$72.2K
SCHA icon
157
Schwab U.S Small- Cap ETF
SCHA
$22.3B
$878K 0.04%
45,014
-136,552
-75% -$2.92M
DEO icon
158
Diageo
DEO
$49.5B
$791K 0.04%
4,546
+110
+2% +$20.9K
PCAR icon
159
PACCAR
PCAR
$70.4B
$788K 0.04%
14,364
-32
-0.2% -$1.8K
GLD icon
160
SPDR Gold Trust
GLD
$133B
$768K 0.04%
4,560
-1,660
-27% -$290K
IYE icon
161
iShares US Energy ETF
IYE
$1.73B
$764K 0.04%
20,030
-1,222
-6% -$51.9K
BCRX icon
162
BioCryst Pharmaceuticals
BCRX
$2.35B
$751K 0.04%
70,999
+2,238
+3% +$23.1K
ORCL icon
163
Oracle
ORCL
$367B
$734K 0.04%
10,500
-3,142
-23% -$230K
SCHB icon
164
Schwab US Broad Market ETF
SCHB
$43B
$731K 0.04%
49,593
+6
+0% +$96
D icon
165
Dominion Energy
D
$61.3B
$723K 0.04%
9,058
+284
+3% +$23.5K
FISV
166
Fiserv Inc
FISV
$28.8B
$720K 0.04%
8,085
KLAC icon
167
KLA
KLAC
$236B
$718K 0.04%
22,500
+250
+1% +$8.41K
JAAA icon
168
Janus Henderson AAA CLO ETF
JAAA
$29.1B
$703K 0.04%
+14,335
New +$712K
SCHM icon
169
Schwab US Mid-Cap ETF
SCHM
$14.5B
$691K 0.03%
33,030
+579
+2% +$13.4K
VTI icon
170
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$677K 0.03%
3,589
+28
+0.8% +$5.75K
T icon
171
AT&T
T
$159B
$664K 0.03%
31,699
-9,062
-22% -$181K
SO icon
172
Southern Company
SO
$109B
$662K 0.03%
9,284
+261
+3% +$19.2K
MUSA icon
173
Murphy USA
MUSA
$11.4B
$646K 0.03%
2,774
TXN icon
174
Texas Instruments
TXN
$255B
$638K 0.03%
4,149
-350
-8% -$58.9K
MGK icon
175
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.1B
$636K 0.03%
17,495

Similar funds

Grimes & Company's Q2 2022 Portfolio in Review

As of Q2 2022, Grimes & Company held 310 positions worth $1.98B, up 3.4% from $1.92B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Grimes & Company deployed $343M of net new capital in Q2 2022, opening 10 new positions and adding to 122 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 2,728,540 shares worth $300M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $56.5M trimmed.

  • Grimes & Company's largest Q2 2022 buy was iShares 0-1 Year Treasury Bond ETF: 2,728,540 shares worth $300M.
  • Grimes & Company added most to JPMorgan Ultra-Short Income ETF in Q2 2022, an estimated $316M increase.
  • Grimes & Company's biggest Q2 2022 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $56.5M.
  • Grimes & Company fully exited State Street Industrial Select Sector SPDR ETF in Q2 2022, selling an estimated $25.4M.
  • Grimes & Company's ten largest holdings make up 50% of its $1.98B portfolio in Q2 2022.
  • Grimes & Company opened 10 new positions and closed 37 in Q2 2022.
  • Grimes & Company's portfolio value rose 3.4% quarter-over-quarter to $1.98B.

Based on Grimes & Company's 13F filing for Q2 2022, filed 22 Jul 2022.